Although the Sepsis 2030 Global Working Group Meeting was held in Germany in September 2023, it was in 2024 that, thanks to that first meeting, the Global Sepsis Agenda was consolidated, seeking to reduce mortality from this disease by 20% over the next six years.
Content made with information from the website: globalsepsisalliance.org
On September 10, 2024, the Global Sepsis Alliance officially launched the 2030 Global Agenda for Sepsis in the German Parliament. This historic event was spearheaded by the chairman of the German Bundestag's Subcommittee on Global Health and was held in collaboration with the UNITE Parliamentarians Network for Global Health, the Virchow Foundation and the Sepsis Stiftung
The 2030 Global Agenda for Sepsis is the first global strategy developed under the leadership of the Global Sepsis Alliance, with the engagement of 70 partner and member organizations from GSA and Regional Sepsis Alliances across Africa, Asia-Pacific, the Caribbean, the Eastern Mediterranean, Europe, Latin America and North America.
bioMérieux is committed to international cooperation for the prevention and treatment of Sepsis. This is why we highlight the importance of this Global Agenda.
These were the highlights of the meeting in Germany:
Assessment of the 2030 Agenda: evaluations were made about the progress since the implementation of the Sepsis 2030 Agenda, including analysis of the challenges faced globally.
International collaboration: the collaboration between the different actors involved in the fight against sepsis was strengthened, including governments, health organizations, research institutions and health professionals.
Strategies for the future: Strategies to improve prevention, early diagnosis and treatment of sepsis were discussed.
Access to care: The meeting emphasized on the importance of ensuring equitable access to timely and quality medical care for patients with sepsis.
Research and development: Research needs to develop new therapies, technologies and strategies to combat sepsis were raised..
Public awareness: The importance of increasing public awareness of sepsis to promote early detection and timely access to care was also discussed.
Key players and KOLs include:
Global Organizations:
- World Health Organization (WHO): It was a major player, coordinating the Global Sepsis Agenda and promoting the implementation of the Sepsis Agenda 2030.
- Global Sepsis Alliance (GSA): This organization drove global collaboration to combat sepsis and coordinated the participation of multiple institutions.
- World Health Organization (WHO) Global Sepsis Alliance: The global partnership between WHO and GSA was a key player in the fight against sepsis.
a global entre la OMS y la GSA, un actor fundamental en la lucha contra la sepsis.
Research and Education Institutions:
- Heidelberg University Sepsis Research Institute (Germany): Led research on sepsis and collaborated in the development of prevention and treatment strategies.
- University of Oxford (UK): Participated in the development of diagnostic tools and analysis of sepsis data.
KOLs (Key Opinion Leaders):
- Dr. Derek Angus (United States): A recognized sepsis expert, president of the GSA, and advocate for the Sepsis Agenda 2030.
- Dr. Marie-Louise Denis (France): A specialist in epidemiology and infection control, she collaborated in defining strategies to improve care for patients with sepsis.
- Dr. R. Graham Cooke (United Kingdom): Sepsis research expert and chairman of the Global Sepsis Alliance (GSA).
Other institutions:
- Ministries of Health from various countries: representatives from ministries of health from countries such as Germany, United Kingdom, United States, Canada, Australia, and others, actively participated in the meeting, sharing experiences and coordinating efforts.
- Non-governmental organizations: NGOs such as Save the Children, Médecins Sans Frontières, and others participated in discussions on the importance of prevention and access to care in low-income countries.
The meeting in Germany was crucial in advancing the Global Sepsis Agenda, bringing together key players and KOLs from the global health arena. The meeting generated a strong commitment to continue advancing the fight against Sepsis worldwide.
Read the full story at: https://tinyurl.com/myeb8yz9
At bioMérieux, we have a shared global concern: the treatment of Sepsis.
We understand the specific challenges involved in the timely and appropriate treatment of sepsis.
That's why we have assembled the only integrated SEPSIS SOLUTION on the market that covers the entire diagnostic pathway to impact therapy from initiation to optimization and discontinuation.
Commenti